W Feng

No ORCID on file · 2 papers in corpus

rct 2026

[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial]

Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20250421-00161

Objective: To evaluate the efficacy and safety of triptorelin acetate microspheres for injection compared with triptorelin acetate for injection in the treatment of endometriosis. Methods: A total of 392 patients with endometriosis were pro…

article 1992

Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin

Bone and mineral ·doi:10.1016/0169-6009(92)90854-7

In young women chronic use of luteinizing hormone releasing hormone (LHRH) agonists such as buserelin to treat endometriosis leads to estrogen-deficiency bone loss. Tamoxifen citrate is an estrogen agonist/antagonist which protects the skel…